Normalization of Neuroinflammation: A New Strategy for Treatment of Persistent Pain and Memory/Emotional Deficits in Chronic Pain
Xian-Guo Liu
DOI: https://doi.org/10.2147/JIR.S379093
IF: 4.5
2022-09-10
Journal of Inflammation Research
Abstract:Xian-Guo Liu Pain Research Center and Department of Physiology, Zhongshan School of Medicine of Sun Yat-sen University, Guangzhou, People's Republic of China Correspondence: Xian-Guo Liu, Pain Research Center and Department of Physiology, Zhongshan School of Medicine of Sun Yat-sen University, 74 Zhongshan Road2, Hemulou 806, Guangzhou, 510080, People's Republic of China, Tel/Fax +86 87331956, Email Chronic pain, which affects around 1/3 of the world population and is often comorbid with memory deficit and mood depression, is a leading source of suffering and disability. Studies in past decades have shown that hyperexcitability of primary sensory neurons resulting from abnormal expression of ion channels and central sensitization mediated pathological synaptic plasticity, such as long-term potentiation in spinal dorsal horn, underlie the persistent pain. The memory/emotional deficits are associated with impaired synaptic connectivity in hippocampus. Dysregulation of numerous endogenous proteins including receptors and intracellular signaling molecules is involved in the pathological processes. However, increasing knowledge contributes little to clinical treatment. Emerging evidence has demonstrated that the neuroinflammation, characterized by overproduction of pro-inflammatory cytokines and glial activation, is reliably detected in humans and animals with chronic pain, and is sufficient to induce persistent pain and memory/emotional deficits. The abnormal expression of ion channels and pathological synaptic plasticity in spinal dorsal horn and in hippocampus are resulting from neuroinflammation. The neuroinflammation is initiated and maintained by the interactions of circulating monocytes, glial cells and neurons. Obviously, unlike infectious diseases and cancer, which are caused by pathogens or malignant cells, chronic pain is resulting from alterations of cells and molecules which have numerous physiological functions. Therefore, normalization (counterbalance) but not simple inhibition of the neuroinflammation is the right strategy for treating neuronal disorders. Currently, no such agent is available in clinic. While experimental studies have demonstrated that intracellular Mg 2+ deficiency is a common feature of chronic pain in animal models and supplement Mg 2+ are capable of normalizing the neuroinflammation, activation of upregulated proteins that promote recovery, such as translocator protein (18k Da) or liver X receptors, has a similar effect. In this article, relevant experimental and clinical evidence is reviewed and discussed. Keywords: ion channels, synaptic plasticity, cytokine, glial cell, monocytes The prevalence of chronic pain is around 30% in the world population 1–3 and around 2/3 chronic pain patients suffer from memory deficit and mood depression. 4–7 In spite of intensive studies for decades worldwide, clinical treatment of chronic pain is still largely unmet. Understanding the mechanisms underlying the chronic pain and its comorbidities is important scientifically and clinically. Pain, a most common chief complaint in clinic, 8 is redefined as an unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage in 2020. 9 According to physiological function, pain is classified into nociceptive (physiological) pain and pathological pain. Nociceptive pain is a pain triggered by activation of nociceptors. It serves as an alarm system and protects tissues from further damage, while pathological pain is a consequence of injury and disease, manifested as allodynia (decrease in pain threshold), hyperalgesia (increase in response to noxious stimuli) and spontaneous pain. Clinically, pain is divided into acute pain and chronic pain. The acute pain is identical to physiological pain. Whereas chronic pain is pain persisting beyond the expected healing period. In clinic practice, the pain that lasts or recurs for longer than 3 months is defined as chronic pain. 10 The short-lasting pathological pain is also protective, such as the pain hypersensitivity induced by skin burning that favors recovery by avoiding touching the injured tissues. In contrast, chronic pain is a leading source of human suffering and disability without any beneficial effect. 11 Mechanistically, chronic pain is mediated by nociceptive pain, neuropathic pain and nociplastic pain. 12 Persistent nociceptive pain is most common form of chronic pain, such as osteoarthritis pain 13 produced by mechanical stimuli due to bone destruction and chemical stimuli by substance P, K + and inflammatory mediators released by damaged tissues. Neuropathic pain is redefined as pain arising as a direct consequence of a lesion or disease affecting the somatosensory -Abstract Truncated-
immunology